High-frequency repetitive transcranial magnetic stimulation is associated with sustained improvement in cannabis use disorder: a one-year, two-phase, three-arm randomized study

Read full text Summarise with VIRAT
Authors: Albert Kar Kin Chung, Sau Wan Tang, Cheuk Yin Tse, Y. Doug Dong, Johnson Kai Chun Law, Welton Leung
Cited by: 0
References: 41

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Aim: High-frequency repetitive transcranial magnetic stimulation (rTMS) targeting the dorsolateral prefrontal cortex (DLPFC) shows promise in treating substance use disorders, but its efficacy for cannabis use disorder (CUD) is less well established. This 12-month, two-phase, three-arm, prospective, open-label study evaluated the short- and long- term effects of high-frequency rTMS over the left DLPFC in individuals with moderate to severe CUD across three treatment schedules. Methods: In the "active rTMS phase", 18 participants (12 men, mean age 24.89) were first randomized in a 1:1:1 ratio to receive 20 rTMS sessions with 2400 pulses of 15 Hz per session over three treatment schedules for 2, 4, or 5 weeks. All participants then entered a 12-month observational "maintenance phase" without further active rTMS treatments. Outcome assessments included Severity of Dependence Scale (SDS) score, MCQ-SF, CUD severity, frequency of use, abstinence, and CPQ at baseline, post-treatment, and at 3, 6, and 12 months. Results: < 0.05, hedge's g ranged -1.86 - -0.76). No consistent differences were observed between the three schedules. Conclusions: These findings provide support for the safety and the potential short- and long-term treatment effects associated with high-frequency rTMS over the DLPFC for reducing cannabis dependence and severity of CUD. Further large-scale studies are needed to differentiate the optimal treatment scheduling when using rTMS for CUD. This study was registered at clinicaltrials.gov (NCT05292547). Clinical Trial Registration: clinicaltrials.gov, identifier NCT05292547.

Fields of Study & Subjects

Transcranial Magnetic Stimulation Studies Substance Abuse Treatment and Outcomes Cannabis and Cannabinoid Research

Publication details

Journal / source
Frontiers in Psychiatry
Volume
17
Pages
1757627–1757627
Publication date
30 March 2026
Language
EN